시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 감기약 및 독감 치료제 시장 보고서(2025년)
Cold And Flu Drugs Global Market Report 2025
상품코드 : 1750943
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,521,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,426,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,330,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감기약 및 독감 치료제 시장 규모는 향후 수년간 급성장이 예상됩니다. 사례 증가, 면역력을 높이는 보충제의 인기가 높아지고, 셀프 메디케이션에 대한 의식 증가 등에 기인하고 있습니다. 이 시기의 주요 동향으로서는 맞춤형 의료, 배합제나 자연 요법의 개발, 점비약이나 흡입기의 주된 발전, 전략적 제휴, 즉효성이 있는 제제의 개발 등을 들 수 있습니다.

바이러스 감염증의 빈도 증가가 향후 감기약 및 독감 치료제 시장의 확대를 견인할 것으로 예측됩니다. 바이러스 감염의 증가는 주로 여행 증가로 인해 발생하며, 이는 바이러스가 지역과 국가 간에 확산되어 새로운 인구에 도달하고 발병을 일으킬 수 있기 때문입니다. 예를 들면, 2025년 1월, 미국을 거점으로 해, 아메리카에 있어서의 국제 보건 협력에 중점을 두는 기관인 범미 보건 기구(Pan American Health Organization)은 2025년 1월 초순 세계의 인플루엔자 양성률은 22.05%로 계절적으로 20% 증가했다고 보고했습니다.

감기약 및 독감 치료제 시장의 주요 기업은 인공첨가물을 포함하지 않는 보다 안전하고 자연적인 대체품을 아이들에게 제공하기 위해 깨끗한 시판약(일반의약품(OTC)) 등 혁신적인 제품의 개발에 주력하고 있습니다. 의약품은 처방전 없이 구입할 수 있는 의약품으로, 두통이나 감기, 가벼운 통증 등 일상적인 증상의 치료에 자주 사용됩니다. 2023년 9월, 미국에 본사를 둔 청정 의약품 회사인 Genexa Inc.는 어린이 다중 증상 감기 및 독감, 어린이 주간 및 야간 기침 완화 가치 팩을 포함한 청정 장외 어린이 의약품을 출시했습니다. 감미료, 보존료를 사용하지 않고, 효과적인 유효 성분을 배합하고 있어 아이의 감기나 인플루엔자의 증상에, 보다 안전하고 자연스러운 선택지를 제공함과 동시에, 발열, 인후통, 코 막힘 등의 증상을 완화합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Cold and flu drugs are pharmaceutical medications designed to alleviate symptoms associated with the common cold and influenza (flu). These medications help relieve symptoms such as fever, cough, congestion, sore throat, body aches, and others, improving comfort and supporting recovery.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of cold and flu drugs include antihistamines, expectorants, bronchodilators, decongestants, and other variants. Antihistamines are drugs that block histamine receptors to relieve allergy and cold symptoms such as sneezing, itching, and nasal congestion. These drugs come in various dosage forms, including tablets, capsules, syrups, lozenges, and others. They are used for a range of conditions, including congenital pituitary dwarfism, acquired pituitary dwarfism, genetic syndromes, and other hormonal disorders. These medications are administered to patients across various age groups, including pediatric, adolescent, adult, and geriatric populations. They are used by several end-users, such as hospitals, specialized clinics, homecare settings, pharmaceutical companies, and research institutions.

The cold and flu drugs market research report is one of a series of new reports from The Business Research Company that provides cold and flu drugs market statistics, including the cold and flu drugs global market size, regional shares, competitors with the cold and flu drugs market share, detailed cold and flu drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the cold and flu drugs. This cold and flu drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold and flu drugs market size has grown rapidly in recent years. It will grow from $17.35 billion in 2024 to $19.19 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth observed during the historic period can be attributed to the increasing aging population, the growing popularity of over-the-counter (OTC) medications, expanding urbanization, rising demand for herbal and natural remedies, and higher healthcare expenditure.

The cold and flu drugs market size is expected to see rapid growth in the next few years. It will grow to $28.54 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth projected during the forecast period can be attributed to the increasing prevalence of seasonal influenza, the rise in air pollution contributing to respiratory infections, the growing cases of antibiotic resistance, the rising popularity of immunity-boosting supplements, and heightened awareness about self-medication. Key trends during this period include personalized medicine, the development of combination products and natural remedies, advancements in nasal sprays and inhalers, strategic collaborations, and the creation of fast-acting formulations.

The growing frequency of viral infections is expected to drive the expansion of the cold and flu drugs market in the future. A viral infection is caused when viruses invade and multiply within host cells, leading to a variety of symptoms. The rise in viral infections is primarily due to increased travel, which facilitates the spread of viruses across regions and countries, enabling them to reach new populations and cause outbreaks. Cold and flu drugs help manage viral infections by alleviating symptoms such as fever, congestion, and pain, offering relief while the immune system works to fight the virus. For example, in January 2025, the Pan American Health Organization, a U.S.-based agency focused on international health cooperation in the Americas, reported a 22.05% influenza positivity rate globally in early January 2025, marking a 20% seasonal increase. Thus, the rising incidence of viral infections is contributing to the growth of the cold and flu drugs market.

Leading companies in the cold and flu drugs market are focusing on developing innovative products, such as clean over-the-counter (OTC) medicines, to provide safer, natural alternatives for children, free from artificial additives. Over-the-counter (OTC) medicines are drugs that can be purchased without a prescription, commonly used for treating everyday conditions such as headaches, colds, and minor pain. For instance, in September 2023, Genexa Inc., a U.S.-based clean medicine company, launched clean OTC children's medicines, including the Kids' Multi-Symptom Cold & Flu and Kids' Daytime + Nighttime Cough Relief Value Pack. These products feature effective active ingredients without artificial dyes, sweeteners, or preservatives, providing a safer and more natural alternative for treating children's cold and flu symptoms, while offering relief for issues such as fever, sore throat, and congestion.

In February 2023, Vir Biotechnology Inc., a U.S.-based biotechnology firm, formed a partnership with GlaxoSmithKline to develop new therapies for influenza. This collaboration aims to ensure continued access to sotrovimab for authorized patients, while also jointly advancing the development of new treatments for influenza and other respiratory illnesses. Additionally, Vir Biotechnology is pursuing next-generation solutions for COVID-19 and potential future coronavirus outbreaks. GlaxoSmithKline is a U.K.-based biopharma company specializing in over-the-counter (OTC) medications for cold and flu symptoms.

Major players in the cold and flu drugs market are Johnson & Johnson, Roche Holding AG, Bayer AG, Sanofi S.A., Viatris Inc., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Pyxus International Inc., Glenmark Pharmaceuticals Ltd., The Kroger Co., Saphnix Life Sciences, Arlak Biotech Pvt Ltd, AdvaCare Pharma, Sterling Pharmaceuticals, Biophar Lifesciences Pvt Ltd, Nutra Respiro.

North America was the largest region in the cold and flu drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold and flu drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold and flu drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold and flu drugs market consist of sales of cough suppressants, nasal sprays, antiviral medications, sore throat sprays, and fever reducers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold And Flu Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold and flu drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cold and flu drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold and flu drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cold And Flu Drugs Market Characteristics

3. Cold And Flu Drugs Market Trends And Strategies

4. Cold And Flu Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold And Flu Drugs Growth Analysis And Strategic Analysis Framework

6. Cold And Flu Drugs Market Segmentation

7. Cold And Flu Drugs Market Regional And Country Analysis

8. Asia-Pacific Cold And Flu Drugs Market

9. China Cold And Flu Drugs Market

10. India Cold And Flu Drugs Market

11. Japan Cold And Flu Drugs Market

12. Australia Cold And Flu Drugs Market

13. Indonesia Cold And Flu Drugs Market

14. South Korea Cold And Flu Drugs Market

15. Western Europe Cold And Flu Drugs Market

16. UK Cold And Flu Drugs Market

17. Germany Cold And Flu Drugs Market

18. France Cold And Flu Drugs Market

19. Italy Cold And Flu Drugs Market

20. Spain Cold And Flu Drugs Market

21. Eastern Europe Cold And Flu Drugs Market

22. Russia Cold And Flu Drugs Market

23. North America Cold And Flu Drugs Market

24. USA Cold And Flu Drugs Market

25. Canada Cold And Flu Drugs Market

26. South America Cold And Flu Drugs Market

27. Brazil Cold And Flu Drugs Market

28. Middle East Cold And Flu Drugs Market

29. Africa Cold And Flu Drugs Market

30. Cold And Flu Drugs Market Competitive Landscape And Company Profiles

31. Cold And Flu Drugs Market Other Major And Innovative Companies

32. Global Cold And Flu Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold And Flu Drugs Market

34. Recent Developments In The Cold And Flu Drugs Market

35. Cold And Flu Drugs Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기